TuDao Medical: A Rising Power in Surgical Robotics with Dual Product Approvals

Since 2015, the Chinese government has strongly supported the development of innovative medical devices, with medical robots listed as a key area of support.

Meanwhile, companies such as Intuitive Surgical, Medtronic, and Stryker have established a presence in the surgical robotics sector, attracting more innovative enterprises to develop surgical robots. Nevertheless, China’s surgical robotics industry remains in its early stages of development.

However, regions such as Beijing and Shanghai have currently included surgical robots in their medical insurance coverage, significantly lowering the threshold for their adoption. In the future, surgical robots are expected to be covered by medical insurance in more regions, thereby accelerating their widespread application. It is foreseeable that with the implementation of supportive policies and innovative developments by domestic enterprises, the surgical robot industry will usher in a period of prosperous growth.As a leading player in the field, Tuodao Medical Technology Co., Ltd. (hereinafter referred to as “Tuodao Medical”) has recently obtained regulatory approvals for its independently developed TuoShou Orthopedic Surgical Robot and Mobile C-arm X-ray Machine, marking the official launch of Tuodao’s comprehensive spinal surgery solution.

Among them, the Tuodao orthopedic surgical robot is the first domestically approved orthopedic surgical robot to have completed a randomized controlled clinical trial against similar products. Its clinical precision, surgical outcomes (excellent and good rates of screw placement), and image display clarity all surpass those of the clinical control products. Its market approval will accelerate the intelligent transformation of orthopedic surgery, rapidly enhance the clinical application level of orthopedic surgical robots, break through the limitations of traditional orthopedic procedures, and hold significant importance for achieving equitable and universal access to high-quality medical resources.

TuoShou integrates real-time image navigation and robotic technologies to intelligently analyze intraoperative imaging data and autonomously establish positioning channels, achieving clinical precision at the sub-millimeter level (<1mm). Compared with traditional surgery, it offers the advantages of higher positioning accuracy and smaller surgical incisions, thereby facilitating the intelligent transformation of orthopedic procedures. After years of R&D accumulation, TuoShou has achieved groundbreaking advancements in core technologies, boasting industry-leading clinical precision and distinct advantages in safety and surgical efficiency.

Tuodao Orthopedic Surgical Robot

Since May 27, 2021, Tuodao Medical has initiated clinical trials of its orthopedic surgical robot at three clinical trial centers. During the trials, the TuoShou system gained recognition and trust from physicians due to its outstanding clinical performance.

Another certified product, the mobile C-arm X-ray machine, leverages Tuodao Medical’s leading integrated technology and features an innovative all-in-one fused design, providing physicians with a flexible and spacious surgical environment. Equipped with an industry-leading CMOS flat-panel detector and a high-power split-type high-voltage generator, it delivers exceptional imaging field of view and precision, achieving “high-quality, low-dose” imaging to safeguard the health of both patients and medical staff.

 Mobile C-arm X-ray Machine

Dr. Cheng Min, Chairman of Tuodao Medical, stated: “The regulatory approval and market launch of these two products mark a significant milestone in our company’s development. They will soon be working alongside orthopedic surgeons to benefit patients. Guided by clinical needs, Tuodao Medical remains committed to continuous innovation, establishing a diversified product portfolio rooted in the local market, and deepening the integration of industry, academia, research, and clinical practice. We strive to become a trusted assistant to more physicians, delivering greater well-being to both doctors and patients.”

Tuodao Medical has secured consecutive approvals for two blockbuster products over the past two years, demonstrating that its R&D capabilities and team scale have ranked among the industry’s leaders. As competition intensifies in the surgical robotics sector, the addition of this formidable player holds significant importance for advancing domestic substitution and promoting smart healthcare.

As a manufacturer of surgical robots and provider of smart healthcare solutions, Tuodao Medical has strategically laid out its presence in five key sectors related to surgical robotics: orthopedics, laparoscopy, percutaneous puncture, natural orifice transluminal endoscopic surgery (NOTES), and medical imaging equipment. By deeply cultivating department-specific and procedure-specific applications, the company has built a robust pipeline of surgical robot products for departments including orthopedics, general surgery, gynecology, urology, and radiology.

To date, Tuodao Medical has commercialized two products, with four in preclinical development and three on the verge of entering registrational clinical trials. We have every reason to believe that the commercialization pace of Tuodao Medical’s products will continue to accelerate. A new heavyweight player has set sail in the surgical robotics sector, and we look forward to its impressive performance in the future.